J
J. Rahman
Researcher at New York University
Publications - 8
Citations - 139
J. Rahman is an academic researcher from New York University. The author has contributed to research in topics: Biology & Medicine. The author has an hindex of 1, co-authored 1 publications receiving 8 citations.
Papers
More filters
Journal ArticleDOI
A genome-scale screen for synthetic drivers of T cell proliferation
Mateusz Legut,Zoran Gajic,Maria Francesca Guarino,Zharko Daniloski,J. Rahman,Xinhe Xue,Congyi Lu,Lu Lu,Eleni P. Mimitou,Stephanie Hao,Teresa Davoli,Catherine Diefenbach,Peter Smibert,Neville E. Sanjana +13 more
TL;DR: In this paper , the authors identify positive regulators of T cell functions through overexpression of around 12,000 barcoded human open reading frames (ORFs), which increased the proliferation and activation of primary human CD4+ and CD8+ T cells and their secretion of key cytokines such as interleukin-2 and interferonγ.
Journal ArticleDOI
A genome-scale screen for synthetic drivers of T cell proliferation
Mateusz Legut,Zoran Gajic,Maria Francesca Guarino,Zharko Daniloski,J. Rahman,Xinhe Xue,Congyi Lu,Lu Lu,Eleni P. Mimitou,Stephanie Hao,Teresa Davoli,Catherine Diefenbach,Peter Smibert,Neville E. Sanjana +13 more
TL;DR: In this article , the authors identify positive regulators of T cell functions through overexpression of around 12,000 barcoded human open reading frames (ORFs), which increased the proliferation and activation of primary human CD4+ and CD8+ T cells and their secretion of key cytokines such as interleukin-2 and interferonγ.
Journal ArticleDOI
Initial Mapping of the New York City Wastewater Virome.
TL;DR: The viral communities in New York City (NYC) wastewater are profiled using metagenomic data collected in November 2014, showing that phages accounted for the largest viral component of the sewage samples and that specific virus communities were associated with local environmental conditions within boroughs.
Posted ContentDOI
Proteomic discovery of chemical probes that perturb protein complexes in human cells
Michael R. Lazear,Jarrett R. Remsberg,Martin G. Jaeger,Katie Rothamel,Hsuan-lin Her,Kristen E. DeMeester,Evert Njomen,Simon J. Hogg,J. Rahman,Landon R. Whitby,Sang Joon Won,Michael A. Schafroth,Daisuke Ogasawara,Minoru Yokoyama,Garrett Lindsey,Haoxin Li,Jason Germain,Sabrina Barbas,Joan Vaughan,Thomas W. Hanigan,Vincent F. Vartabedian,Christopher J. Reinhardt,Melissa M. Dix,Seong Joo Koo,In-Sook Heo,John R. Teijaro,Gabriel M. Simon,Brahma Ghosh,Omar Abdel-Wahab,Kay Ahn,Alan Saghatelian,Bruno Melillo,Stuart L. Schreiber,Gene W. Yeo,Benjamin F. Cravatt +34 more
TL;DR: In this paper, a function-first proteomic strategy that uses size exclusion chromatography (SEC) to assess the global impact of electrophilic compounds on protein complexes in human cells is described.
Journal ArticleDOI
Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia.
Eric T. Wang,Jose Mario Bello Pineda,Won Jun Kim,Sisi Chen,Jessie Bourcier,Maximilian Stahl,Simon J. Hogg,Jan Philipp Bewersdorf,Cuijuan Han,Michael Singer,Daniel Cui,Caroline Erickson,Steven Tittley,A. Penson,Katherine Knorr,Robert F. Stanley,J. Rahman,Gnana P. Krishnamoorthy,James A. Fagin,Emily Creger,Elizabeth A. McMillan,Chi Ching Mak,Matthew D. Jarvis,Carine Bossard,Darrin M. Beaupre,Robert K. Bradley,Omar Abdel-Wahab +26 more
TL;DR: In this paper , the authors performed CRISPR-Cas9 screens across a broad range of therapies used in acute myeloid leukemia to identify genomic determinants of drug response, uncovering a selective dependency on RNA splicing factors whose loss preferentially enhances response to the BCL2 inhibitor venetoclax.